ABOUT

Targeted Pharmaceuticals, LLC.

60 Prescott Street

Worcester MA 01609

Located in the WPI Biotech Park

SOCIAL
  • White LinkedIn Icon
  • White Facebook Icon

© 2018-2019 Targeted Pharmaceuticals, LLC

A cannabinoid-based 

biopharmaceutical company.

 

We are focused on drug discovery & personalized medicine derived from plant-based therapeutics and combination therapies.

The new frontier between medicine and botany.

The new frontier between medicine and botany.

OUR PIPELINE

Clinical Trial

DCIS Breast Cancer & Cannabinoids

First & only company to be awarded a patent that includes using any molecule, including cannabinoids, as an autophagy inhibitor.  Several cell studies and clinical trial on live breast cancer patients. 

ONGOING - PHASE I / II

Clinical Trial

HIV Affiliated Dementia & Cannabinoids

Several cell studies on the use of cannabinoids to treat HIV affiliated dementia  and other central nervous system (CNS) diseases and viruses.

ONGOING - PHASE I / II

Development

Data Driven, Personalized 

Cannabinoid Care Platform

Developing a personalized medicine data platform that combines molecular data and patient data to predict outcomes and prescribe medicine.

ONGOING

 

MEET TARGETED PHARMACEUTICALS 

Our goal is to bring precision medicine and real science to the cannabis industry by linking the molecular structure of humans to cannabinoid compounds.

Technology and data are at the core of what we do.  We are very much a data-driven technology company focused on using data for personalized cannabinoid care.     

 

TOP TEAM & ADVISORS FROM 

 

TOP TEAM & ADVISORS FROM 

George Mason University

National Cancer Institute

Harvard University 

Worcester Polytechnic Institute

McLean Hospital

Food & Drug Adminstration

OUR TEAM

ALAN CARPINO, CO-FOUNDER

Mr. Carpino has been a senior executive in the pharmaceutical and bioscience space and has worked for Thermo Fisher Scientific, Millennium Pharmaceuticals, and Fluidigm.  He is a graduate of Mt Ida College and Florida Southern College.

JARET CHRISTOPHER, CHAIRMAN

Jaret is a serial entrepreneur with 20+ experience building technology and data-driven companies.  He is the founder of Cannabis Venture Partners, Sprout, MortgageCEO, and TrueAdvantage.  Jaret holds a BS in Engineering from Worcester Polytechnic Institute.

DR. LANCE LIOTTA, PhD, MD, CHIEF MEDICAL OFFICER

Dr. Liotta has served as Co-Director and Co-Founder of the Center for Applied Proteomics and Molecular Medicine at George Mason University. Prior to this appointment, Dr. Liotta served as Chief of the Laboratory of Pathology for the National Cancer Institute, and the Deputy Director of National Institute of Health, Co-Director of the NCI/FDA Clinical Proteomics Program, and Director of the Anatomic Pathology Residency Program.  Dr. Liotta has more than 100 issued or allowed patents and more than 690 publications.  He is Board Certified in Anatomic Pathology and is Medical Director of the GMU CAP/CLIA certified clinical proteomics Lab.  He is a founder of Theranostics Health and Ceres Nanosciences.

DR. T. WILSON WOO, MD, SCIENTIFIC ADVISOR

Dr. Woo is the Medical Director at McLean Hospital for the Harvard University Brain Tissue & Resource Center and the Laboratory of Cellular Neuropathology.  Dr. Woo’s research interest is in defining the nature of cortical circuitry disturbances in schizophrenia and other psychotic disorders, and in understanding the developmental neurobiological pathways that lead to these disturbances.

DR. PAMELA WEATHERS, PhD, SCIENTIFIC ADVISOR, BOTANY

Dr. Weathers is an internationally recognized expert on Artemisia annua and artemisinin, having worked with the plant and its phytochemicals including the antimalarial drug, artemisinin.   She is a Fellow of AAAS and SIVB, won many awards, given many national and international presentations, reviews manuscripts for many journals and proposals for many national and international funding agencies. She is an Associate Editor for two journals. Her lab was the first to genetically transform A. annua.  She spearheaded the edible A. annua concept for treating malaria and other diseases and has led all research to date on the project to establish proof-of-concept.

 

GET

IN TOUCH

Targeted Pharmaceuticals is a cannabinoid-based drug discovery company.